{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:35:45Z","timestamp":1775151345823,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,10,6]],"date-time":"2005-10-06T00:00:00Z","timestamp":1128556800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1007\/s10067-005-0028-x","type":"journal-article","created":{"date-parts":[[2005,10,5]],"date-time":"2005-10-05T09:36:34Z","timestamp":1128504994000},"page":"537-539","source":"Crossref","is-referenced-by-count":31,"title":["Abnormalities in the bone mineral metabolism in HIV-infected patients"],"prefix":"10.1007","volume":"25","author":[{"given":"A. M.","family":"Garc\u00eda Aparicio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Mu\u00f1oz Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. R.","family":"Arribas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. J.","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. E.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Coya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Mart\u00edn Mola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,10,6]]},"reference":[{"key":"28_CR1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1359\/jbmr.2001.16.1.2","volume":"16","author":"C Kuhne","year":"2001","unstructured":"Kuhne C, Heufelder A, Hofbauer L (2001) Bone and mineral metabolism in human immunodeficiency virus infection. J Bone Miner Res 16:2\u20139","journal-title":"J Bone Miner Res"},{"key":"28_CR2","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(05)77775-8","volume":"351","author":"A Carr","year":"1998","unstructured":"Carr A, Samaras K, Chisholm DJ, Cooper DA (1998) Abnormal fat distribution and use of protease inhibitors. Lancet 351:1736","journal-title":"Lancet"},{"key":"28_CR3","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/00002030-200107060-00009","volume":"15","author":"D Nolan","year":"2001","unstructured":"Nolan D, Upton R, McKinnon E, John M, James I, Adler B et al (2001) Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir. AIDS 15:1275\u20131280","journal-title":"AIDS"},{"key":"28_CR4","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-200003100-00005","volume":"14","author":"P Tebas","year":"2000","unstructured":"Tebas P, Powderly GW, Claxton S, Marin D, Tantisiriwat W, Teitelbaum LS et al (2000) Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 14:F63\u2013F67","journal-title":"AIDS"},{"issue":"13","key":"28_CR5","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1097\/00002030-200309050-00010","volume":"17","author":"D Bruera","year":"2003","unstructured":"Bruera D, David DO, Bergoglio LM, Zumudio J (2003) Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy. AIDS 17(13):1917\u20131923","journal-title":"AIDS"},{"key":"28_CR6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00002030-200303070-00006","volume":"17","author":"M Cozzolino","year":"2003","unstructured":"Cozzolino M, Vidal M, Arcidiacono MV, Tebas P, Yarasheski K, Dusso A (2003) HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D. AIDS 17:513\u2013520","journal-title":"AIDS"},{"issue":"11","key":"28_CR7","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1210\/jcem.83.11.5270","volume":"83","author":"C Haug","year":"1998","unstructured":"Haug C, Aukrust P, Haug E, Morkrid L, Muller F, Froland S (1998) Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis. J Clin Endocrinol Metab 83(11):3832\u20133838","journal-title":"J Clin Endocrinol Metab"},{"key":"28_CR8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9343(92)90682-2","volume":"93","author":"MJ McKenna","year":"1992","unstructured":"McKenna MJ (1992) Differences in vitamin D status between countries in young adults and the elderly. Am J Med 93:69\u201377","journal-title":"Am J Med"},{"issue":"9","key":"28_CR9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0025-7753(00)71283-8","volume":"114","author":"P Aguado","year":"2000","unstructured":"Aguado P, Garc\u00e9s MV, Gonzalez Casaus ML, del Campo MT, Rich J, Torrijos A et al (2000) High prevalence of vitamin D deficiency in postmenopausal women at a rheumatology office in Madrid. Evaluation of 2 vitamin D prescription regimens. Med Clin (Barc) 114(9):326\u2013330","journal-title":"Med Clin (Barc)"},{"issue":"3","key":"28_CR10","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1210\/jcem.86.3.7327","volume":"86","author":"P Lips","year":"2001","unstructured":"Lips P, Duong T, Oleksik A, Black D, Cummings S, Cox D (2001) A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 86(3):1212\u20131221","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"28_CR11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4158\/EP.8.4.266","volume":"8","author":"F Bandeira","year":"2002","unstructured":"Bandeira F, Caldas G, Freese E, Griz L, Faria M, Bandeira C (2002) Relationship between serum vitamin D status and clinical manifestations of primary hyperparathyroidism. Endocr Pract 8(4):266\u2013270","journal-title":"Endocr Pract"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-005-0028-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-005-0028-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-005-0028-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:42:43Z","timestamp":1559119363000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-005-0028-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,6]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["28"],"URL":"https:\/\/doi.org\/10.1007\/s10067-005-0028-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,6]]}}}